News and Trends 14 Nov 2022 A new treatment for tackling epidermolysis bullosa By Jordi Casals, president, EMEA, Amryt Pharma Epidermolysis bullosa (EB), sometimes described as “the worst disease you’ve never heard of,” is a group of rare and distressing inherited skin disorders primarily diagnosed in young children. The genetic mutations that cause EB can result in the skin being extremely fragile. Any physical contact with the skin […] November 14, 2022 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 14 Nov 2022 RSV cases are rising fast in children. Early detection can help. By Shawn Gaskell, MilliporeSigma RSV-related hospitalizations for 2022 have already surged to unusually high numbers, surpassing cumulative cases typically reported in late December each year, and we’re not even one month into the season. While no age group is immune to RSV— respiratory syncytial virus— and the trouble it can cause, young children are being […] November 14, 2022 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 14 Nov 2022 A biotech boom manifesting real results in rare pediatric diseases By Bob Coughlin, managing director, life sciences, JLL For the last two years, the pandemic has resulted in the explosive growth in life sciences. The world watched in awe and anticipation as biotech successfully raced to develop vaccines, therapeutics and diagnostics for Covid-19. It has been a good moment for an industry that deserves such […] November 14, 2022 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 11 Nov 2022 Program management support: accelerating growth for early stage biotechs More academic groups, new start-ups, biotechs and small pharma companies are turning to external consultants for professional program management support and guidance to help them progress their ideas into medicines for patients. Ian Hollingsworth, associate director of product development at Boyds, a global drug development consultancy, explains the common reasons why academic spinouts and small […] November 11, 2022 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Opinion 25 Oct 2022 Precision medicine research must lose its Eurocentricity Precision medicine research relies on genetic testing at scale, but how do we reach more diverse patient populations and collect nationally representative samples? Patrick Short, CEO and co-founder of Sano Genetics, and Natasha Ratcliffe, director of community engagement and partnerships at Couch Health, explain how Eurocentricity is holding back genetics, and what can be done. […] October 25, 2022 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Opinion 24 Oct 2022 Hiding in plain sight: how to solve bioscience’s software problem Guy Levy-Yurista, CEO of the experiment platform developer Synthace, gives his take on what’s missing in increasingly software-dependent life sciences labs: a holistic mindset for improving experimental methods. There’s a major problem holding back progress in biotech, and more widely in the life sciences. It’s not an obvious one, but based on the conversations I […] October 24, 2022 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 20 Oct 2022 The role of long-read sequencing in validating CRISPR outcomes Neil Ward, general manager of PacBio EMEA With applications of CRISPR across the spectrum of microbial, plant and gene therapy increasingly being realised, enthusiasm from the research community for this technology is not expected to wane. It has the potential to, among other applications, create knock-out animal models for use in research, revolutionise agriculture and […] October 20, 2022 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 17 Oct 2022 CRISPR/Cas9: Challenges and outlook from an investor’s perspective A Q&A with Fady Riad, CEO of consulting company Centurion Life Sciences. How did CRISPR/Cas9 revolutionize gene editing and the broader life sciences industry? CRISPR/Cas9 is undoubtedly one of the greatest scientific advancements of the last 100 years. In 2012, Jennifer Doudna and Emanuelle Charpentier published a peer-reviewed paper discussing the use of CRISPR/Cas9 in […] October 17, 2022 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Sponsored by Biognosys 27 Sep 2022 Using the power of proteomics to predict immunotherapy responses in melanoma and beyond Next-generation proteomics has a vital role to play in the search for new biomarkers of immunotherapy response. Recent studies in melanoma presented at the European Society for Medical Oncology (ESMO) Congress highlight how these insights have the potential to transform cancer care. The recent success of immunotherapies that manipulate the patient’s immune system to recognize […] September 27, 2022 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
More News! 13 Sep 2022 Research charity calls on scientists, engineers, and technology experts to transform dialysis treatment Following its successful MedTech competition earlier this year, the UK’s largest kidney research charity, Kidney Research UK, has launched a new competition aimed at innovations in dialysis that will have a significant impact on patients’ lives. In collaboration with IN-PART’s Discover platform, this year’s competition will encourage scientists, academics, engineers and technology experts to propose […] September 13, 2022 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Opinion 6 Sep 2022 Meeting tech transfer challenges when manufacturing new biopharmaceuticals With increasingly complex therapeutics arriving almost monthly, efficient technology transfer between biopharma and manufacturers is more important than ever. Ken Forman, senior director of product strategy at IDBS, explains how good digital strategies can avoid common pitfalls in the tech transfer process. Biopharmaceutical lifecycle management (BPLM) is the key to delivering novel therapies and lifesaving […] September 6, 2022 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Opinion 1 Sep 2022 The evolution of diabetes management Diabetes management has progressed leaps and bounds in the last 100 years. Francine Kaufman, Chief Medical Officer of Senseonics, outlines how far the field has progressed and what is on the horizon for diabetes patients. This year marks 100 years since insulin was first available to treat diabetes – an incredible milestone. One of the […] September 1, 2022 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email